Approval · Notice of Compliance 11363 · 2010
EVRA: Notice of Compliance 11363
Issued May 7, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11363
- Date
- May 7, 2010
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the adhesive component of the patch and the drug product specification
- Therapeutic class
- Hormonal contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRA | Not yet assigned | — |
Medicinal ingredients
- NORELGESTROMIN 6 MG per PATCH
- ETHINYL ESTRADIOL 0.6 MG per PATCH